Get started
Keyword

Ktrans

Description: Ktrans is a quantitative parameter from dynamic contrast-enhanced imaging that estimates the transfer of contrast agent between blood plasma and tissue.
OpenAlex ID: keywords/ktrans
Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols
1999 · Paul S. Tofts, Gunnar Brix, et al. · Journal of Magnetic Resonance Imaging · 3,146
PDF
Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging
1997 · Paul S. Tofts · Journal of Magnetic Resonance Imaging · 1,478
Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI
2006 · Geoff J.M. Parker, Caleb Roberts, et al. · Magnetic Resonance in Medicine · 660
PDF
Biomarkers of response and resistance to antiangiogenic therapy
2009 · Rakesh K. Jain, Dan G. Duda, et al. · Nature Reviews Clinical Oncology · 571
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
2004 · Meng Law, Stanley Yang, et al. · PubMed · 510
A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
2009 · A. Gregory Sorensen, Tracy T. Batchelor, et al. · Cancer Research · 395
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
2012 · James P. B. O'Connor, Alan Jackson, et al. · Nature Reviews Clinical Oncology · 348
Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI
2009 · Deanna L. Langer, Theodorus H. van der Kwast, et al. · Journal of Magnetic Resonance Imaging · 333
PDF
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results
2006 · Thomas E. Yankeelov, Martin Lepage, et al. · Magnetic Resonance Imaging · 314
Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR Imaging
2010 · Aytekin Oto, Arda Kayhan, et al. · Radiology · 290
Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model
2005 · Thomas E. Yankeelov, Jeffrey J. Luci, et al. · Magnetic Resonance Imaging · 279
Dynamic Contrast-Enhanced MRI of Prostate Cancer at 3 T: A Study of Pharmacokinetic Parameters
2007 · Iclal Ocak, Marcelino Bernardo, et al. · American Journal of Roentgenology · 276
Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging
2002 · Carmel Hayes, Anwar R. Padhani, et al. · NMR in Biomedicine · 270
PDF
Choroid Plexus Volume and Permeability at Brain MRI within the Alzheimer Disease Clinical Spectrum
2022 · Jong Duck Choi, Yeonsil Moon, et al. · Radiology · 267
Prostate Tissue Composition and MR Measurements: Investigating the Relationships between ADC, T2,Ktrans,ve, and Corresponding Histologic Features
2010 · Deanna L. Langer, Theodorus H. van der Kwast, et al. · Radiology · 266
Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
2008 · Mei-Lin W. Ah-See, Andreas Makris, et al. · Clinical Cancer Research · 263
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study
2005 · Glenn Liu, Hope S. Rugo, et al. · Journal of Clinical Oncology · 260
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
2009 · A. Craig Lockhart, Mace L. Rothenberg, et al. · Journal of Clinical Oncology · 232
PDF
Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
2001 · M L George, A S K Dzik-Jurasz, et al. · British journal of surgery · 231
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacodynamic Biomarker Study of Sorafenib in Metastatic Renal Carcinoma
2008 · Olwen M. Hahn, Cheng Yang, et al. · Journal of Clinical Oncology · 230
Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy
2005 · Martin D. Pickles, Martin Lowry, et al. · Breast Cancer Research and Treatment · 213
Active Crohn's Disease in the small bowel: Evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging
2011 · Aytekin Oto, Arda Kayhan, et al. · Journal of Magnetic Resonance Imaging · 202
PDF
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI
2012 · M.L. Marinovich, F. Sardanelli, et al. · The Breast · 198
PDF
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
2009 · W.R. Jarnagin, L.H. Schwartz, et al. · Annals of Oncology · 193
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma
2008 · Keith T. Flaherty, Mark A. Rosen, et al. · Cancer Biology & Therapy · 193
Works count: 2,160
Citation count: 41,630
Year
Topic
Type